Yulong Eco-Materials Limited announced that it will focus its energies into building an incubator laboratory in Nashville,TN for the development of cell and extracellular vesicle (EV) based therapeutics. Dr. Jason Sanders recently relocated to Nashville and the Company is now negotiating lab space near the Vanderbilt University area. EV Biologics will develop a new biotechnology laboratory to advance its cell culture, EV isolation and nano-scale bioanalytical methods. Laboratory innovation will focus on enhancement of the natural biological properties of MSCs as well as the purification and standardization of the EVs they produce. This R&D incubator lab will provide the framework for novel biopharmaceutical development to treat life-threatening clinical conditions and will be the site for initial production of its first EV drugs. Disease-specific EVs produced by these types of optimized cell lines will be developed into biological drugs seeking FDA approval for several different clinical indications: acute lung injury (eg. COVID-19, influenza, acute respiratory distress syndrome), autoimmune (lupus, multiple sclerosis, rheumatoid arthritis, etc) and systemic inflammatory syndromes, osteoarthritis and other degenerative musculoskeletal disease, neurodegenerative conditions, metabolic diseases and other age-related conditions.